ArticleFrontiers in medicine2026

Early identification of high-risk myelosuppression subtypes in DLBCL patients undergoing R-CHOP chemotherapy.

Keyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.